Lagardere (LGDDF) Short Interest Ratio & Short Volume → Gold Mania (From Stansberry Research) (Ad) Free LGDDF Stock Alerts $22.95 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Lagardere Short Interest DataCurrent Short Volume600 sharesPrevious Short Volume1,700 sharesChange Vs. Previous Month-64.71%Dollar Volume Sold Short$13,770.00Short Interest Ratio / Days to Cover6.0Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume5,250 sharesToday's Volume Vs. Average0% Short Selling Lagardere ? Sign up to receive the latest short interest report for Lagardere and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLGDDF Short Interest Over TimeLGDDF Days to Cover Over TimeLGDDF Percentage of Float Shorted Over Time Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. Lagardere Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024600 shares $13,770.00 -64.7%N/A6 $22.95 3/31/20241,700 shares $39,015.00 No ChangeN/A0.8 $22.95 3/15/20241,700 shares $34,051.00 -37.0%N/A0 $20.03 2/29/20242,700 shares $54,081.00 +58.8%N/A0 $20.03 2/15/20241,700 shares $34,051.00 No ChangeN/A17 $20.03 1/15/20241,700 shares $34,051.00 No ChangeN/A17 $20.03 Get the Latest News and Ratings for LGDDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lagardere and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,700 shares $34,127.50 No ChangeN/A0 $20.08 12/15/20231,700 shares $34,127.50 No ChangeN/A8.5 $20.08 11/30/20231,700 shares $34,943.50 -85.5%N/A1.3 $20.56 11/15/202311,700 shares $240,493.50 No ChangeN/A14.6 $20.56 10/31/202311,700 shares $249,795.00 -10.7%N/A0 $21.35 10/15/202313,100 shares $279,685.00 +1.6%N/A0 $21.35 9/30/202312,900 shares $275,415.00 +0.8%N/A129 $21.35 9/15/202312,800 shares $297,600.00 -11.7%N/A128 $23.25 8/31/202314,500 shares $337,125.00 +13.3%N/A0 $23.25 8/15/202312,800 shares $297,600.00 No ChangeN/A0 $23.25 7/31/202312,800 shares $297,600.00 No ChangeN/A0 $23.25 7/15/202312,800 shares $297,600.00 +2.4%N/A128 $23.25 6/30/202312,500 shares $300,875.00 +5.9%N/A125 $24.07 6/15/202311,800 shares $284,026.00 +0.9%N/A39.3 $24.07 5/31/202311,700 shares $260,325.00 No ChangeN/A117 $22.25 5/15/202311,700 shares $263,367.00 -28.7%N/A0 $22.51 4/30/202316,400 shares $369,164.00 No ChangeN/A164 $22.51 4/15/202316,400 shares $369,164.00 No ChangeN/A164 $22.51 3/31/202316,400 shares $369,164.00 -4.1%N/A82 $22.51 3/15/202317,100 shares $384,921.00 +200.0%N/A0 $22.51 2/28/20235,700 shares $128,307.00 +5.6%N/A57 $22.51 2/15/20235,400 shares $116,424.00 No ChangeN/A27 $21.56 1/31/20235,400 shares $108,324.00 No ChangeN/A0 $20.06 1/15/20235,400 shares $108,324.00 No ChangeN/A0 $20.06 12/30/20225,400 shares $108,324.00 No ChangeN/A54 $20.06 12/15/20225,400 shares $77,760.00 No ChangeN/A54 $14.40 11/30/20225,400 shares $77,760.00 No ChangeN/A0 $14.40 11/15/20225,400 shares $77,760.00 +14.9%N/A0 $14.40 10/31/20224,700 shares $67,680.00 +27.0%N/A47 $14.40 10/15/20223,700 shares $53,280.00 -67.3%N/A0 $14.40 9/30/202211,300 shares $162,720.00 -12.4%N/A113 $14.40 9/15/202212,900 shares $196,725.00 -0.8%N/A129 $15.25 8/31/202213,000 shares $211,250.00 +0.8%N/A130 $16.25 8/15/202212,900 shares $228,201.00 +12,800.0%N/A129 $17.69Investors Alert: The Next Big Thing in Weight Loss (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> LGDDF Short Interest - Frequently Asked Questions What is Lagardere's current short interest? Short interest is the volume of Lagardere shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 600 shares of LGDDF short. Learn More on Lagardere's current short interest. What is a good short interest ratio for Lagardere? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LGDDF shares currently have a short interest ratio of 6.0. Learn More on Lagardere's short interest ratio. Is Lagardere's short interest increasing or decreasing? Lagardere saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 600 shares, a decline of 64.7% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Lagardere stock? Short selling LGDDF is an investing strategy that aims to generate trading profit from Lagardere as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lagardere? A short squeeze for Lagardere occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LGDDF, which in turn drives the price of the stock up even further. How often is Lagardere's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LGDDF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: EOVBF Short Interest Data CTMLF Short Interest Data EDDRF Short Interest Data ISPOW Short Interest Data DRTGF Short Interest Data LSMNF Short Interest Data OOBHF Short Interest Data TNGCF Short Interest Data TNLIY Short Interest Data TNLIF Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:LGDDF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace